United States · FDA National Drug Code directory
Respiratory Syncytial Virus Vaccine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50024-311_31e185e1-1f35-45a6-e063-6394a90aff08
- Product NDC
- 50024-311
- Form
- SUSPENSION
- Composition / generic term
- Respiratory Syncytial Virus Vaccine
- Labeler
- ROVI Pharma Industrial Services S.A.
- Marketing category
- DRUG FOR FURTHER PROCESSING
- Marketing start / end (source format)
- 20240531
- Source listing expiry
- 20261231
Source-listed ingredients
- RNA-100-AR02 — 50 ug/.5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 SYRINGE in 1 CARTON (50024-311-10) / .5 mL in 1 SYRINGE (50024-311-11) · 50024-311-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →